Stereotactic body radiation therapy for primary and metastatic liver tumors

Translational Oncology

Volumn 6, Issue 4, 2013, Pages 442-446

  Liu, Erqi ^a   Stenmark, Matthew H ^a   Schipper, Matthew J ^a,b   Balter, James M ^a   Kessler, Marc L ^a   Caoili, Elaine M ^c   Lee, Oliver E ^b   Ben Josef, Edgar ^a   Lawrence, Theodore S ^a   Feng, Mary ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; TUMOR MARKER;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGE GUIDED RADIOTHERAPY; LIVER DISEASE; LIVER FUNCTION; LIVER TOXICITY; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84881073708     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.12448     Document Type: Article

References (17)

1. Wong S L, Mangu P B, Choti M A, Crocenzi T S, Dodd GD III, Dorfman G S, Eng C, Fong Y, Giusti A F, Lu D, et al. (2010). American Society Of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28, 493-508.
2. Lawrence TS, Robertson JM, Anscher MS,Jirtle RL,Ensminger WD, and Fajardo LF (1995). Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31, 1237-1248.
3. Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, Knol J, Dawson LA, Pan C, and Lawrence TS (2005). Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 23, 8739-8747.
4. Herfarth KK, Debus J, Lo F, Bahner ML, Rhein B, Fritz P, Hoss A, Schlegel W, and Wannenmacher MF (2001). Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19,164-170.
5. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, and Schefter T.E (2009). Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27, 1579-1584.
6. Schefter T E, Kavanagh B D, Timmerman R D, Cardenes H R, Baron A, and Gaspar LE (2005). A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62,1371-1378.
7. Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, et al. (2011). Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 117, 4060-4069.
8. Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, and Koong AC (2010). Dose-escalation study of single-fraction stereo-tactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78, 486-493.
9. Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, and Flentje M (2006). Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45, 838-847.
10. Roberson PL, McLaughlin PW, Narayana V, Troyer S, Hixson GV, and Kessler ML (2005). Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate. Med Phys 32, 473-482.
11. Dawson LA, Brock KK, Kazanjian S, Fitch D, McGinn CJ, Lawrence TS, Ten Haken RK, and Balter J (2001). The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51, 1410-1421.
12. Chan JL, Lee SW, Fraass BA, Normolle DP, Greenberg HS, Junck LR, Gebarski SS, and Sandler HM (2002). Survival and failure patterns of high-grade gliomas after t ee-dimensional conformal radiotherapy. J Clin Oncol 20, 1635-1642.
13. Lin DY and Wei LJ (1989). The robust inference for the Cox proportional hazards model. J Am Stat Assoc 84, 1074-1078.
14. Agrawal S and Belghiti J (2011). Oncologic resection for malignant tumors of the liver. Ann Surg 253, 656-665.
15. Liu E, Stenmark MH, Schipper MJ, Caoili EM, Ben-Josef E, Lawrence TS, and Feng M (2012). SBRT as an alternative to RFA for the treatment of primary and metastatic liver tumors. J Clin Oncol 30, 158.
16. Normolle D, Pan C, Ben-Josef E, and Lawrence T (2010). Adaptive trial of personalized radiotherapy for intrahepatic cancer. Per Med 7, 197-204.
17. Imamura H, Sano K, Sugawara Y, Kokudo N, and Makuuchi M (2005).Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12, 16-22.